Study on the variables related to blood glucose control and safety of long-term ingestion of sterile packaged cooked rice.
Not Applicable
Completed
- Conditions
- Healthy volunteers
- Registration Number
- JPRN-UMIN000030710
- Lead Sponsor
- iigata Bio-Research Park , Inc
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
1.Diabetes under medical treatment. 2.Volunteers having severe diseases (e.g. liver, kindney, heart, blood diseases, and infections requiring the notification) 3.Volunteers received gastrectomy, enterectomy, and gastro-intestinal diseases, juded to be inappropriate for this study. 4.Pregnant, women having the possibility, and lactating women. 5.Volunteers rejected participating in this study by chief investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms influence blood glucose control with long-term sterile packaged cooked rice ingestion?
How does long-term consumption of sterile packaged cooked rice compare to standard dietary interventions for blood glucose management?
Are there specific biomarkers that predict individual response to sterile packaged cooked rice in glucose regulation?
What are the potential adverse events associated with prolonged ingestion of sterile packaged cooked rice and how can they be managed?
What related compounds or combination therapies could enhance the safety and efficacy of sterile packaged cooked rice for blood glucose control?